Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2025-12-25 @ 4:11 AM
NCT ID:
NCT00005120
Eligibility Criteria:
Inclusion Criteria
Patients may be eligible for this study if they:
* Are at least 18 years old.
* Agree to use effective methods of birth control during the study.
* Have a CD4 cell count of 200 cells/mm3 or more.
* Have HIV levels of 5000 copies/ml or more.
Exclusion Criteria
Patients will not be eligible for this study if they:
* Have abnormal blood tests.
* Have had a reaction to study medication.
* Have a history of opportunistic (AIDS-related) infection or cancer.
* Are being treated for active pulmonary tuberculosis.
* Have a fever of 39 degrees C or more within 14 days of beginning study treatment.
* Are unable to take medications by mouth.
* Have an abnormal chest X-ray or ECG within 30 days of beginning study treatment.
* Have hepatitis, hemophilia, or other blood disorder.
* Have significant heart, stomach, intestinal, liver, nerve, or kidney problems.
* Have a condition which may affect ability to participate in this study, such as drug or alcohol abuse or a serious mental disorder.
* Have taken anti-HIV drugs in the past.
* Are taking certain medications.
* Have had a blood transfusion within the 3 months prior to entering the study.
* Have had radiation or chemotherapy within 16 days before the screening visit or plan to receive such treatment during the study.
* Are pregnant or breast-feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00005120
Study Brief:
Protocol Section:
NCT00005120